Show simple item record

dc.contributor.authorAnitua Aldekoa, Eduardo
dc.contributor.authorPrado, Roberto
dc.contributor.authorGuadilla Arsuaga, Jorge
dc.contributor.authorAlkhraisat, Mohammad H.
dc.contributor.authorLaiz, Patricia
dc.contributor.authorPadilla, Sabino
dc.contributor.authorGarcía Balletbó, Montserrat
dc.contributor.authorCugat, Ramón
dc.date.accessioned2023-08-01T11:04:01Z
dc.date.available2023-08-01T11:04:01Z
dc.date.issued2023-07-18
dc.identifier.citationInternational Journal of Molecular Sciences 24(14) : (2023) // Article ID 11581es_ES
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/10810/62084
dc.description.abstractThe treatment of chondral and osteochondral defects is challenging. These types of lesions are painful and progress to osteoarthritis over time. Tissue engineering offers tools to address this unmet medical need. The use of an autologous cartilage construct consisting of hyaline cartilage chips embedded in plasma rich in growth factors (PRGF) has been proposed as a therapeutic alternative. The purpose of this study was to dig into the potential mechanisms behind the in vitro remodelling process that might explain the clinical success of this technique and facilitate its optimisation. Chondrocyte viability and cellular behaviour over eight weeks of in vitro culture, type II collagen synthesis, the dual delivery of growth factors by hyaline cartilage and PRGF matrix, and the ultrastructure of the construct and its remodelling were characterised. The main finding of this research is that the cartilage fragments embedded in the three-dimensional PRGF scaffold contain viable chondrocytes that are able to migrate into the fibrin network, proliferate and synthesise extracellular matrix after the second week of in vitro culture. The characterization of this three-dimensional matrix is key to unravelling the molecular kinetics responsible for its efficacy.es_ES
dc.description.sponsorshipThis study received funding from the Basque Country Government, within the Hazitek program, and support program for collaborative research in strategic area, within the project named EndoCarTech (grant number ZL-2020/00937).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectchondral defectses_ES
dc.subjectparticulated cartilagees_ES
dc.subjectPACIes_ES
dc.subjectplatelet-rich plasmaes_ES
dc.subjectPRGFes_ES
dc.subjectchondrocytees_ES
dc.subjectgrowth factorses_ES
dc.subjectfibrines_ES
dc.titleThe Dual-Responsive Interaction of Particulated Hyaline Cartilage and Plasma Rich in Growth Factors (PRGF) in the Repair of Cartilage Defects: An In Vitro Studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2023-07-28T12:22:15Z
dc.rights.holder© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/24/14/11581es_ES
dc.identifier.doi10.3390/ijms241411581
dc.departamentoesCirugía, radiología y medicina física
dc.departamentoeuKirurgia,erradiologia eta medikuntza fisikoa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).
Except where otherwise noted, this item's license is described as © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).